Production (Stage)
Burning Rock Biotech Limited
BNR
$3.64
$0.2557.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.56% | 4.47% | 2.03% | -16.00% | -16.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.56% | 4.47% | 2.03% | -16.00% | -16.00% |
| Cost of Revenue | -11.80% | -14.51% | -10.60% | -13.01% | -13.01% |
| Gross Profit | 12.19% | 14.90% | 8.15% | -17.32% | -17.32% |
| SG&A Expenses | -51.04% | -50.77% | -54.57% | -28.07% | -28.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.80% | -39.64% | -44.78% | -27.60% | -27.60% |
| Operating Income | 88.09% | 71.76% | 78.17% | 36.37% | 36.37% |
| Income Before Tax | 89.20% | 52.67% | 79.40% | 37.42% | 37.42% |
| Income Tax Expenses | 22.71% | 398.11% | -54.75% | -59.32% | -59.32% |
| Earnings from Continuing Operations | 89.04% | 49.70% | 79.33% | 37.47% | 37.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.04% | 49.70% | 79.33% | 37.47% | 37.47% |
| EBIT | 88.09% | 71.76% | 78.17% | 36.37% | 36.37% |
| EBITDA | 97.52% | 74.46% | 96.10% | 44.02% | 44.02% |
| EPS Basic | 89.55% | 50.17% | 79.51% | 37.57% | 37.57% |
| Normalized Basic EPS | 89.71% | 74.79% | 79.58% | 37.51% | 37.51% |
| EPS Diluted | 89.55% | 50.17% | 79.51% | 37.57% | 37.57% |
| Normalized Diluted EPS | 89.71% | 74.79% | 79.58% | 37.51% | 37.51% |
| Average Basic Shares Outstanding | 4.95% | 0.94% | 0.88% | 0.15% | 0.15% |
| Average Diluted Shares Outstanding | 4.94% | 0.95% | 0.88% | 0.15% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |